Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.

PR Newswire August 19, 2013

Ready to Profit? Start Here Now With MU, PCLN, JNJ and XOM

Marketwired August 16, 2013

In the Know, Smart Investing in DRYS, UAL, JNJ and FCX

Marketwired August 15, 2013

Key to Success, How to Profit: WFT, MS, JNJ and FITB

Marketwired August 14, 2013

In the Know, Smart Investing in JNJ, LLY and XOM

Marketwired August 13, 2013

Royalty Pharma Partners with Aisling Capital and Clarus Ventures in Recent Ibrutinib Royalty Purchase

PR Newswire August 12, 2013

Don't Miss Gains in JNJ, JPM, GMCR and GRPN

Marketwired August 9, 2013

Secrets to Making Money in FOXA, PCLN, POT and JNJ

Marketwired August 8, 2013

Before the Crowd, How We Found BIDU, LNKD, JNJ and AMZN

Marketwired August 6, 2013

Strategy Behind Our Success, We Get in Early: XOM, MELI, WPZ and JNJ

Marketwired August 3, 2013

Perfect Trade Setups, How to Play JNJ, ONNN, KEY and WFT

Marketwired August 2, 2013

Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle

Marketwired August 1, 2013

Perfect Trade Setups, How to Play PEP, LNKD, CAT and JNJ

Marketwired July 25, 2013

The Reason It Trades, What's Moving JNJ, EBAY and WFC

Marketwired July 25, 2013

Quest Diagnostics Sells Ibrutinib Royalty Rights To Royalty Pharma For $485 Million In Cash

PR Newswire July 18, 2013

Johnson & Johnson Reports 2013 Second-Quarter Results:

PR Newswire July 16, 2013

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2013

PR Newswire July 15, 2013

CMS Proposes Permanent Medicare Payment for VisionCare's Telescope Implant for Macular Degeneration

Canada NewsWire July 9, 2013

CMS Proposes Permanent Medicare Payment for VisionCare's Telescope Implant for Macular Degeneration

PR Newswire July 9, 2013

Trial Results, New Facilities, Approved Labels, Spinoffs, and M&As Support Long-Term Growth Strategies - Research Report on Pfizer, Johnson & Johnson, Merck, Zoetis, and AstraZeneca

PR Newswire July 4, 2013